Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (43)

« Back to Publications

Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.

Alam N. et al, (2026), EMBO Mol Med, 18, 873 - 890

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

Structural basis for synergistic antibody protection against the essential malaria invasion complex protein RIPR

Williams BG. et al, (2025)

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Hou MM. et al, (2025), Nat Commun, 16

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.

Harrison TE. et al, (2024), EMBO Mol Med, 16, 2539 - 2559

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.

Barrett JR. et al, (2024), Cell, 187, 4964 - 4980.e21

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.

King LDW. et al, (2024), Cell Rep Med, 5

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Mertens JE. et al, (2024), Vaccine, 42, 3621 - 3629

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.

Williams BG. et al, (2024), Nat Commun, 15

A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions.

Segireddy RR. et al, (2024), Malar J, 23

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5

Harrison TE. et al, (2024)

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex

Williams BG. et al, (2024)

Evaluation of Precision of the Plasmodium knowlesi Growth Inhibition Assay for Plasmodium vivax Duffy-Binding Protein-based Malaria Vaccine Development

Mertens JE. et al, (2024)

Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

King LDW. et al, (2024)

Adeno-associated viral vectored delivery of monoclonal antibody genes against blood-stage malaria

Bardelli M. et al, (2024), HUMAN GENE THERAPY, 35, A130 - A131

Load More